Association between long-term efficacy of cinacalcet and parathyroid gland volume in haemodialysis patients with secondary hyperparathyroidism

por Tanaka, Motoko, Nakanishi, Shohei, Komaba, Hirotaka, Itoh, Kazuko, Matsushita, Kazutaka, Fukagawa, Masafumi
Publicado 2008

Effects of Secondary Hyperparathyroidism Treatment on Improvement in Anemia: Results from the MBD-5D Study

por Tanaka, Motoko, Yoshida, Kazuki, Fukuma, Shingo, Ito, Kazuko, Matsushita, Kazutaka, Fukagawa, Masafumi, Fukuhara, Shunichi, Akizawa, Tadao
Publicado 2016

Indoxyl Sulfate Contributes to mTORC1-Induced Renal Fibrosis via The OAT/NADPH Oxidase/ROS Pathway

por Nakano, Takehiro, Watanabe, Hiroshi, Imafuku, Tadashi, Tokumaru, Kai, Fujita, Issei, Arimura, Nanaka, Maeda, Hitoshi, Tanaka, Motoko, Matsushita, Kazutaka, Fukagawa, Masafumi, Maruyama, Toru
Publicado 2021

A downstream molecule of 1,25-dihydroxyvitamin D3, alpha-1-acid glycoprotein, protects against mouse model of renal fibrosis

por Bi, Jing, Watanabe, Hiroshi, Fujimura, Rui, Nishida, Kento, Nakamura, Ryota, Oshiro, Shun, Imafuku, Tadashi, Komori, Hisakazu, Miyahisa, Masako, Tanaka, Motoko, Matsushita, Kazutaka, Maruyama, Toru
Publicado 2018

Advanced Oxidation Protein Products Contribute to Chronic-Kidney-Disease-Induced Adipose Inflammation through Macrophage Activation

por Arimura, Nanaka, Watanabe, Hiroshi, Kato, Hiromasa, Imafuku, Tadashi, Nakano, Takehiro, Sueyoshi, Miyu, Chikamatsu, Mayuko, Tokumaru, Kai, Nagasaki, Taisei, Maeda, Hitoshi, Tanaka, Motoko, Matsushita, Kazutaka, Maruyama, Toru
Publicado 2023

Indoxyl Sulfate Contributes to Adipose Tissue Inflammation through the Activation of NADPH Oxidase

por Tanaka, Shoma, Watanabe, Hiroshi, Nakano, Takehiro, Imafuku, Tadashi, Kato, Hiromasa, Tokumaru, Kai, Arimura, Nanaka, Enoki, Yuki, Maeda, Hitoshi, Tanaka, Motoko, Matsushita, Kazutaka, Fukagawa, Masafumi, Maruyama, Toru
Publicado 2020

p-Cresyl sulfate, a uremic toxin, causes vascular endothelial and smooth muscle cell damages by inducing oxidative stress

por Watanabe, Hiroshi, Miyamoto, Yohei, Enoki, Yuki, Ishima, Yu, Kadowaki, Daisuke, Kotani, Shunsuke, Nakajima, Makoto, Tanaka, Motoko, Matsushita, Kazutaka, Mori, Yoshitaka, Kakuta, Takatoshi, Fukagawa, Masafumi, Otagiri, Masaki, Maruyama, Toru
Publicado 2015

Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1

por Enoki, Yuki, Watanabe, Hiroshi, Arake, Riho, Sugimoto, Ryusei, Imafuku, Tadashi, Tominaga, Yuna, Ishima, Yu, Kotani, Shunsuke, Nakajima, Makoto, Tanaka, Motoko, Matsushita, Kazutaka, Fukagawa, Masafumi, Otagiri, Masaki, Maruyama, Toru
Publicado 2016

An acute phase protein α(1)-acid glycoprotein mitigates AKI and its progression to CKD through its anti-inflammatory action

por Watanabe, Hiroshi, Fujimura, Rui, Hiramoto, Yuto, Murata, Ryota, Nishida, Kento, Bi, Jing, Imafuku, Tadashi, Komori, Hisakazu, Maeda, Hitoshi, Mukunoki, Ayumi, Takeo, Toru, Nakagata, Naomi, Tanaka, Motoko, Matsushita, Kazutaka, Fukagawa, Masafumi, Maruyama, Toru
Publicado 2021

Advanced oxidation protein products contribute to chronic kidney disease‐induced muscle atrophy by inducing oxidative stress via CD36/NADPH oxidase pathway

por Kato, Hiromasa, Watanabe, Hiroshi, Imafuku, Tadashi, Arimura, Nanaka, Fujita, Issei, Noguchi, Isamu, Tanaka, Shoma, Nakano, Takehiro, Tokumaru, Kai, Enoki, Yuki, Maeda, Hitoshi, Hino, Shinjiro, Tanaka, Motoko, Matsushita, Kazutaka, Fukagawa, Masafumi, Maruyama, Toru
Publicado 2021

Potential therapeutic interventions for chronic kidney disease‐associated sarcopenia via indoxyl sulfate‐induced mitochondrial dysfunction

por Enoki, Yuki, Watanabe, Hiroshi, Arake, Riho, Fujimura, Rui, Ishiodori, Kana, Imafuku, Tadashi, Nishida, Kento, Sugimoto, Ryusei, Nagao, Saori, Miyamura, Shigeyuki, Ishima, Yu, Tanaka, Motoko, Matsushita, Kazutaka, Komaba, Hirotaka, Fukagawa, Masafumi, Otagiri, Masaki, Maruyama, Toru
Publicado 2017

A synthetic retinoic acid receptor agonist Am80 ameliorates renal fibrosis via inducing the production of alpha-1-acid glycoprotein

por Watanabe, Hiroshi, Bi, Jing, Murata, Ryota, Fujimura, Rui, Nishida, Kento, Imafuku, Tadashi, Nakamura, Yuka, Maeda, Hitoshi, Mukunoki, Ayumi, Takeo, Toru, Nakagata, Naomi, Kurauchi, Yuki, Katsuki, Hiroshi, Tanaka, Motoko, Matsushita, Kazutaka, Fukagawa, Masafumi, Maruyama, Toru
Publicado 2020

Cys34-Cysteinylated Human Serum Albumin Is a Sensitive Plasma Marker in Oxidative Stress-Related Chronic Diseases

por Nagumo, Kohei, Tanaka, Motohiko, Chuang, Victor Tuan Giam, Setoyama, Hiroko, Watanabe, Hiroshi, Yamada, Naoyuki, Kubota, Kazuyuki, Tanaka, Motoko, Matsushita, Kazutaka, Yoshida, Akira, Jinnouchi, Hideaki, Anraku, Makoto, Kadowaki, Daisuke, Ishima, Yu, Sasaki, Yutaka, Otagiri, Masaki, Maruyama, Toru
Publicado 2014

Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes

por Imafuku, Tadashi, Watanabe, Hiroshi, Oniki, Kentaro, Yoshida, Akira, Kato, Hiromasa, Nakano, Takehiro, Tokumaru, Kai, Fujita, Issei, Arimura, Nanaka, Maeda, Hitoshi, Sakamoto, Yuki, Kondo, Nozomi, Morita, Ayami, Saruwatari, Junji, Tanaka, Motoko, Matsushita, Kazutaka, Wada, Takashi, Fukagawa, Masafumi, Otagiri, Masaki, Fitzgerald, Michael L., Jinnouchi, Hideaki, Maruyama, Toru
Publicado 2021